Tuesday's Top Analyst Upgrades and Downgrades: Allstate, ADP, Baker Hughes, Hyatt, Lemonade, Robinhood, Suncor Energy and More

AppLovin Corp. (NYSE: APP): While Morgan Stanley upgraded the stock to Equal Weight from Underweight, the firm also lowered the price target to $60 from $68. The consensus target is $77.71, and the stock ended Monday’s trading at $55.88.

Asana Inc. (NASDAQ: ASAN): RBC Capital Markets downgraded it to Sector Perform from Outperform but also lifted the price target to $70 from $45. The consensus target is $59.18. The shares were last seen on Monday at $74.56, after retreating close to 3% on the day.

Automatic Data Processing Inc. (NYSE: ADP): JPMorgan downgraded the shares to Underweight from Neutral and have a $224 price target. That compares with the lower $210.03 consensus target and Monday’s last trade at $216.56.

Baker Hughes Co. (NYSE: BKR): Goldman Sachs reiterated its Buy rating on the oilfield service giant and has a $28 price target. The firm also added the stock to the Conviction List of top picks. The consensus price target is also $28.00. Monday’s closing trade was reported at $21.28.

CF Industries Holdings Inc. (NYSE: CF) Berenberg upgraded the stock to Buy from Hold and lifted the target price to $60 from $54. The consensus target is $59.06. The stock fell over 4% on Monday to close at $46.39.

Coupa Software Inc. (NASDAQ: COUP): RBC Capital Markets downgrade to Sector Perform from Outperform included a target price cut to $210 from $300. The consensus target is $283.79. Monday’s final trade was reported at $210.86.

Cytek Biosciences Inc. (NASDAQ: CTBK): Goldman Sachs began coverage with a Buy rating and a $28 price target, while Piper Sandler started it at Overweight with a $28 price objective. No consensus target was available as the stock had a recent initial public offering. Since then, the stock has traded between $17.40 and $28.46 a share. Monday’s last trade hit the tape at $22.89, up almost 11% on the day.

Diamondrock Hospitality Co. (NYSE: DRH): The Truist Securities upgrade was to Hold from Sell. The stock has traded in a 52-week range of $4.52 to $11.49 and has a $10.29 consensus price target. The shares closed Monday at $8.58 apiece.

DXC Technology Co. (NYSE: DXC): JPMorgan downgraded it to Underweight from Neutral and has a $45 price target. The consensus target is $44.75, and the final trade on Monday was posted at $41.75.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.